The prognostic value of CYP2C subfamily genes in hepatocellular carcinoma

Cytochrome P2C (CYP2C) subfamily members (CYP2C8,CYP2C9,CYP2C18, and CYP2C19) are known to participate in clinical drug metabolism. However, the association between CYP2C subfamily members and hepatocellular carcinoma (HCC) remains unclear. This study investigated the prognostic value of CYP2C subfa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Wang, Xiangkun, Yu, Tingdong, Liao, Xiwen, Yang, Chengkun, Han, Chuangye, Zhu, Guangzhi, Huang, Ketuan, Yu, Long, Qin, Wei, Su, Hao, Liu, Xiaoguang, Peng, Tao
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2018
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5911570/
https://ncbi.nlm.nih.gov/pubmed/29479826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1299
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados